Belando, Eddie E.
HRN: 24-98-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/12/2024
05/19/2024
IVT
500mg
Q8
T/C Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes